Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON25494
NL-OMON25494
Recruiting
Not Applicable

Hemodynamic Adaptation to Pregnancy and Placenta-related Outcome

Erasmus MC, University Medical Center Rotterdam0 sites300 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPreeclampsiaPregnancy induced hypertensionFetal growth restrictionSmall for gestational ageCardiovascular disease riskPre-eclampsie (zwangerschapsvergiftiging)Zwangerschapshypertensie (hoge bloeddruk in de zwangerschap)Foetale groeivertragingTe laag geboortegewichtCardiovasculair risicoprofiel

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PreeclampsiaPregnancy induced hypertensionFetal growth restrictionSmall for gestational ageCardiovascular disease riskPre-eclampsie (zwangerschapsvergiftiging)Zwangerschapshypertensie (hoge bloeddruk in de zwangerschap)Foetale groeivertragingTe laag geboortegewichtCardiovasculair risicoprofiel
Sponsor
Erasmus MC, University Medical Center Rotterdam
Enrollment
300
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC, University Medical Center Rotterdam

Eligibility Criteria

Inclusion Criteria

  • •\- Age above 18 years old

Exclusion Criteria

  • •\- Women unable or unwilling to provide informed consent
  • •\- Women currently breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Hemodynamic Adaptation to Pregnancy and Placenta-related Outcome (HAPPO study)Maternal cardiovascular adaptation and utero(placental) vascular developmentpreeclampsiasmall for gestational age10010273
NL-OMON55842Erasmus MC, Universitair Medisch Centrum Rotterdam300
Recruiting
Not Applicable
Hemodynamic Adaptation in the Peripartum Period using Impedance cardiography (HAPPI).
NL-OMON54780Erasmus MC, Universitair Medisch Centrum Rotterdam60
Active, not recruiting
Not Applicable
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: Aldosterone
EUCTR2007-000727-17-NLErasmus MC10
Completed
Not Applicable
Hemodynamic Changes During Normal PregnancyPregnancy
NCT00682201Oslo University Hospital120
Not yet recruiting
Not Applicable
The study of fetal and placental blood flow improvement effect with the deep ocean waterfetal grouth restriction Hypertensive disorder of pregnancy
JPRN-UMIN000036414Kochi medical school hospital20